Back
Nuveen Real Asset Income and Growth Fund Vs. Ingevity Industry Stock Comparison
Sell
40
JRI
Nuveen Real Asset Income and Growth Fund
Last Price:
13.27
Seasonality Move:
-0.86%
Sell
15
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
40
Nuveen Real Asset Income and Growth Fund (JRI)
is a Sell
Is Nuveen Real Asset Income and Growth Fund a Buy, Sell or Hold?
- The current Nuveen Real Asset Income and Growth Fund [JRI] share price is $13.28. The Score for JRI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- JRI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
JRI Stock Price Chart
What is Nuveen Real Asset Income and Growth Fund's stock price today?
-
The Nuveen Real Asset Income and Growth Fund share price today is $13.28
The current trend is moderately bearish and JRI is experiencing slight selling pressure.
JRI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 51.82 | Buy |
Chaikin Money Flow: | -49276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 47.28 | Sell |
Chaikin Money Flow: | 509201 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.32 - 40.1) | Sell |
Bollinger Bands (100): | (36.91 - 47.49) | Sell |
JRI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.45 | Sell |
20-day SMA: | 13.35 | Sell |
50-day SMA: | 12.97 | Buy |
200-day SMA: | 12.02 | Buy |
8-day EMA: | 13.39 | Sell |
20-day EMA: | 13.32 | Sell |
50-day EMA: | 13.01 | Buy |
200-day EMA: | 12.2 | Buy |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.05 | Sell |
20-day SMA: | 37.78 | Sell |
50-day SMA: | 38.09 | Sell |
200-day SMA: | 44.29 | Sell |
8-day EMA: | 37.4 | Sell |
20-day EMA: | 37.93 | Sell |
50-day EMA: | 38.95 | Sell |
200-day EMA: | 43.92 | Sell |
Nuveen Real Asset Income and Growth Fund Earnings Growth & JRI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Nuveen Real Asset Income and Growth Fund Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ingevity Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |